A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...
The fundraising was co-led by Radical Ventures, which specialises in AI software companies, and European healthcare venture firm Sofinnova Partners. Other investors include Jeff Dean, Google’s chief ...
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results